May 27 was a weak volume day for Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), with an upside momentum. The trading capacity for the firm moved to 1148497 contracts. Over the past week, the average daily trading volume stood at about 1976420 shares per day. The regular session started at $3.52 but as the trading went on, the stock escalated, ending the session with a gain of 3.44%. Its shares last traded at a price of $3.61 per share.

Catalyst Pharmaceuticals, Inc. (CPRX): A 88.02% Rally In This Year — But Still Has Room To Grow 130.75%

According to 6 stock analysts, Catalyst Pharmaceuticals, Inc., is being kept at an average Outperform, rating, with at least 6.46% of shares outstanding that are currently legally short sold. The shares of the corporation went down by -39.83% during the previous month. So far this year, the stock had gone up by 88.02%. With these types of results, analysts are more optimistic than before, leading 6 of analysts who cover Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) to advise their clients to include it in their buy candidate list. However, on the Street, the shares for the company have been tagged a $8.33 price target, indicating that the shares will rally 130.75% from its current levels. At the moment, the stock is trading for about -41.4% less than its 52-week high.

Catalyst Pharmaceuticals, Inc. Last Posted 220% Sales Growth

Revenue for the most recent quarter grew by 220% from the last quarter, totaling $1.6 million.

CPRX Is -15.18% Away From SMA20

The shares of the company (CPRX) staged the smart recovery and have roared back some 95.14% after stumbling to its new 52-weeks low. The share price volatility of the stock remained at 7.17% for the week and by increasing the timeframe to a month, the volatility stood at 12.07%. As for the share price, it has gone below the 20 days moving average and is now hovering within a distance of -15.18%. Currently the price is sitting at -22.44% lower than its 50 days moving average. Analyzing the last five market sessions, the stock was able to report -4.75% losses, thus going up by 9.05%, compared with its 200-day moving average of $3.362.

Axcelis Technologies, Inc. (NASDAQ:ACLS) Has 2 Buy or Better Ratings

Axcelis Technologies, Inc. (ACLS) was also brought into the spotlight with a $0.34 rise. As the regular session came to an end, the price changed by 2.21% to $15.7. The trading of the day started with the price of the stock at $15.47. However, at one point, in the middle of the day, the price touched a high of $15.81 before it finally returned some of the gains. Analyzing ACLS this week, analysts seem to be content with keeping to their neutral forecast call at 2.2. Axcelis Technologies, Inc. analysts gave 2 buy-equivalent recommendations, 0 sells and 2 holds. This company shares tumbled -37.62% from their most recent record high of $25.17 and now hold $506.01 million in market value of equity.

Axcelis Technologies, Inc. Underpriced by 97.45%

ACLS’s mean recommendation on Reuter’s scale has been revised upward from 1.6 thirty days ago to 2 now. This is an indication of a hold consensus from the analysts’ society. They expect that Axcelis Technologies, Inc. (ACLS) price will be reaching a mean target of $24.8 a share. This implies that they believe the stock has what it takes to lift the price another 57.96%. The recent close goes a long way in suggesting that the stock price is being underpriced by a 97.45% compared to the most bullish target.

Axcelis Technologies, Inc. (ACLS) Returns -11.8% This Year

The company during the last trade was able to reach a volume of 222942 shares. That activity is comparable to their recent volume average trend of nearly 222900 shares which they recorded over a period of one week. The stock price volatility for last week at the close of regular trading was 2.92%, pushing the figure for the whole month to now reaching 3.69%. Axcelis Technologies, Inc. price was kept to a minimum $15.47 in intra-day trade and has returned -11.8% this year alone. At a certain point in the past four quarters, the shares traded as low as $15.15 but made a 3.63% recovery since then. [T5]